Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RAB7: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RAB7 (RAB7, member RAS oncogene family) is a small GTPase critical for endolysosomal trafficking, autophagosome maturation, and lysosomal function. Mutations cause Charcot-Marie-Tooth disease type 2B. Dysfunction implicated in Alzheimer's disease, Parkinson's disease, and Huntington's disease.
No AI portrait yet
| Gene Symbol | RAB7 |
| Full Name | Member RAS Oncogene Family |
| Aliases | RAB7, member RAS oncogene family |
| Function | RAB7 is a master regulator of late endosomal/lysosomal trafficking: - Late endosome maturation: Regulates transition from early to late endosomes - Lysosomal fusion: Controls SNARE-mediated fusion wit |
| Molecular Weight | 23 kDa |
| Amino Acids | 207 aa |
| Exons | 7 |
| Pathways | PI3K |
| GeneCards | RAB7 |
| Human Protein Atlas | RAB7 |
| GTPase-activating proteins (GAPs) | Accelerate GTP hydrolysis (e.g., TBC1D5, TBC1D15) |
| GDP dissociation inhibitors (GDIs) | Extract GDP-bound RAB7 from membranes for recycling |
| Associated Diseases | Als, Ataxia, disease, Neurodegeneration |
| Interactions | ALZHEIMER'S DISEASE, AMYLOID, AND, ATP6V1G1, AUTOPHAGY, CCT5 |
| KG Connections | 218 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
RAB7["RAB7"]
Als{"Als"}
RAB7 -->|"associated with"| Als
Alzheimer{"Alzheimer"}
RAB7 -->|"regulates"| Alzheimer
Ms{"Ms"}
RAB7 -->|"interacts with"| Ms
Hepatitis{"Hepatitis"}
RAB7 -->|"regulates"| Hepatitis
RAB7 -->|"expressed in"| Alzheimer
RAB7 -->|"regulates"| Ms
Parkinson{"Parkinson"}
RAB7 -->|"interacts with"| Parkinson
RAB7 -->|"interacts with"| Alzheimer
RAB7 -->|"interacts with"| Als
ALS{"ALS"}
RAB7 -->|"causes"| ALS
RILP["RILP"]
RAB7 -->|"activates"| RILP
YAP["YAP"]
RAB7 -->|"activates"| YAP
NRBF2["NRBF2"]
NRBF2 -->|"interacts with"| RAB7
CCZ1_MON1A["CCZ1-MON1A"]
CCZ1_MON1A -->|"activates"| RAB7
NRBF2 -->|"activates"| RAB7
IGF2R["IGF2R"]
IGF2R -->|"associated with"| RAB7
RAB7A["RAB7A"]
RAB7A -->|"associated with"| RAB7
RILP -->|"activates"| RAB7
ATG14["ATG14"]
ATG14 -->|"regulates"| RAB7
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
PARKINSON_S_DISEASE -->|"interacts with"| RAB7
YAP -->|"activates"| RAB7
APP["APP"]
APP -->|"regulates"| RAB7
style RAB7 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| late endosomal pH | responds_to | process | 0.90 |
| IGF2R | regulates | protein | 0.85 |
| RILP | interacts_with | protein | 0.80 |
| V-ATPase | interacts_with | protein | 0.80 |
| Als | associated_with | disease | 0.75 |
| Infection | activates | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Neuropathy | expressed_in | disease | 0.65 |
| Hepatitis | regulates | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| NLRP3 | inhibits | gene | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Parkinson | interacts_with | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Ataxia | implicated_in | disease | 0.65 |
| NLRP3 INFLAMMASOME | causes | pathway | 0.65 |
| Neurodegeneration | implicated_in | disease | 0.65 |
| NLRP3 INFLAMMASOME | activates | pathway | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| TAU PATHOLOGY | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | interacts_with | gene | 0.60 |
| ALZHEIMER DISEASE | regulates | gene | 0.60 |
| PI3KC3 | regulates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| AMYLOID | interacts_with | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| SNAP29 | regulates | gene | 0.60 |
| VAMP8 | regulates | gene | 0.60 |
| RAB7A | regulates | gene | 0.60 |
| TAU | regulates | gene | 0.60 |
| RAB7A | interacts_with | gene | 0.60 |
| RILP | interacts_with | gene | 0.60 |
| ATG14 | regulates | gene | 0.60 |
| Huntingtin | associated_with | protein | 0.60 |
| ENDOSOMES | contributes_to | gene | 0.60 |
| RILP | associated_with | entity | 0.60 |
| Neuron | expressed_in | cell_type | 0.60 |
| Lysosomal Degradation | regulates | pathway | 0.60 |
| RAB7A | activates | entity | 0.60 |
| STING | activates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| V-ATPase | regulates | enzyme | 0.95 |
| Late Endosomal pH Collapse | activates | process | 0.92 |
| RILP | interacts_with | protein | 0.90 |
| WDR91 | interacts_with | protein | 0.90 |
| V-ATPASE | activates | protein | 0.90 |
| CCZ1-MON1A | activates | protein | 0.70 |
| NRBF2 | activates | protein | 0.70 |
| NRBF2 | interacts_with | protein | 0.70 |
| DEMENTIA | causes | disease | 0.65 |
| TBK1 | phosphorylates | gene | 0.65 |
| NEURONS | regulates | cell_type | 0.65 |
| LATE | associated_with | entity | 0.60 |
| NEURODEGENERATION | expressed_in | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| TAU PATHOLOGY | regulates | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| TAU | regulates | gene | 0.60 |
| SLC17A7 | expressed_in | gene | 0.60 |
| CALB1 | expressed_in | gene | 0.60 |
| NGFR | associated_with | gene | 0.60 |
| RAB5 | expressed_in | gene | 0.60 |
| LYSOSOME | associated_with | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| TNF-Α | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| ENDOSOME | associated_with | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| BECLIN1 | associated_with | gene | 0.60 |
| LAMP2 | activates | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| IGF2R | activates | entity | 0.60 |
| GENES | associated_with | gene | 0.60 |
| CCT5 | associated_with | gene | 0.60 |
| SPTLC1 | associated_with | gene | 0.60 |
| RAB7A | causes | gene | 0.60 |
| ATP6V1G1 | activates | gene | 0.60 |
| ATG5 | associated_with | gene | 0.60 |
| IGF2R | associated_with | gene | 0.60 |
| RAB7A | associated_with | gene | 0.60 |
| RILP | activates | gene | 0.60 |
| YAP | activates | gene | 0.60 |
| SREBP2 | activates | gene | 0.60 |
| AND | interacts_with | gene | 0.60 |
| AMYLOID | interacts_with | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.584
neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814
neurodegeneration | 2026-04-03 | 44 hypotheses Top: 0.990
neuroscience | 2026-04-03 | 67 hypotheses Top: 1.000
neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.910
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.63 · 2026-04-13
closed · Rounds: 4 · Score: 0.90 · 2026-04-12
closed · Rounds: 4 · Score: 0.89 · 2026-04-06
closed · Rounds: 3 · Score: 0.95 · 2026-04-04
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
Hypotheses and analyses mentioning RAB7 in their description or question text
No additional research found